|
Volumn 297, Issue 5578, 2002, Pages 102-104
|
Sustained loss of a neoplastic phenotype by brief inactivation of MYC
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CELLS;
GENES;
PHARMACODYNAMICS;
TUMORS;
OSTEOGENIC SARCOMA CELLS;
ONCOLOGY;
4',6 DIAMIDINO 2 PHENYLINDOLE;
DEOXYURIDINE TRIPHOSPHATE DERIVATIVE;
DNA NUCLEOTIDYLEXOTRANSFERASE;
DOXYCYCLINE;
BIOCHEMISTRY;
CANCER;
PHENOTYPE;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
CELL DIFFERENTIATION;
GENE INACTIVATION;
MOUSE;
NEOPLASM;
NONHUMAN;
ONCOGENE MYC;
OSTEOSARCOMA;
PHENOTYPE;
PRIORITY JOURNAL;
TRANSGENIC MOUSE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL DIFFERENTIATION;
CELL DIVISION;
DOXYCYCLINE;
GENE EXPRESSION;
GENE SILENCING;
GENES, MYC;
MICE;
MICE, TRANSGENIC;
NEOPLASM TRANSPLANTATION;
OSTEOCYTES;
OSTEOSARCOMA;
PHENOTYPE;
TRANSGENES;
TUMOR CELLS, CULTURED;
ANIMALIA;
MUS MUSCULUS;
|
EID: 0037025201
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1071489 Document Type: Article |
Times cited : (565)
|
References (26)
|